Your search returned 46 results.

Results
	1.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry MedStar authors: Atkins, Francis Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Plyku D, Hobbs FR, Srinivasan S, Atkins F, Van Nostrand D, Sgouros G Local accession number: 2015_188 Add to cart (remove)
	2.	The Utility of "Blind" 131I treatments for differentiated thyroid cancer: an educational exhibit. MedStar authors: Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_234 Add to cart (remove)
	3.	Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors: Van Nostrand, Douglas Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Hobbs R Brown T Byard J Plyku D Sgouros G Van Nostrand D. Wu D Local accession number: B201872 Add to cart (remove)
	4.	Detection of 131I in public places: a national survey. MedStar authors: Orquiza, Michael H Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Van Nostrand D,Orquiza M, Bloom G Local accession number: 2014.1_131 Add to cart (remove)
	5.	The use of diuretics for increasing radioiodine (RAI) uptake in patients with well-differentiated thyroid cancer MedStar authors: Orquiza, Michael H Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Van Nostrand D Local accession number: 2014.1_135 Add to cart (remove)
	6.	The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors: Elboga, Umut Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_160 Add to cart (remove)
	7.	Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_162 Add to cart (remove)
	8.	Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_236 Add to cart (remove)
	9.	Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_161 Add to cart (remove)
	10.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_235 Add to cart (remove)
	11.	#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_159 Add to cart (remove)
	12.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_233 Add to cart (remove)
	13.	124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G Local accession number: 2013_166 Add to cart (remove)
	14.	Whole body retention of 131I at 24hr versus 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation Local accession number: 2013_231 Add to cart (remove)
	15.	Frequency, duration and severity of salivary side effects in DTC patients with onset at 3 to 12 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors: Gomes Lima, Christiane J Mete, Mihriye Mete, Mihriye Van Nostrand, Douglas Wu, Di Year: 20172016 Citation: Unpublished 2017/04/01 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Gomes Lima CJ Hall JP Khorjekar G McIver B Mete M Van Nostrand D Wu D Local accession number: A2017_314 Add to cart (remove)
	16.	Evaluation of the relationship of reproductive hormones to radioiodine breast uptake in patients with differentiated thyroid cancer: a pilot study. MedStar authors: Kulkarni, Kanchan P Kumar, Anagha Van Nostrand, Douglas Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Kulkarni K Kumar A Van Nostrand D. Wu D Local accession number: B201870 Add to cart (remove)
	17.	Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Atkins F, Van Nostrand D, Orquiza M, Wartofsky L Local accession number: 2013_158 Add to cart (remove)
	18.	Low-iodine diet and urine iodine measurements for 131-I treatments in patients with differentiated thyroid cancer: a comparison of 18 clinical practice guidelines. MedStar authors: Burman, Kenneth D Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman KD Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_571 Add to cart (remove)
	19.	Frequency, duration and severity of salivary effects in DTC patients with onset at 7 weeks to 3 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors: Gomes Lima, Christiane J Mete, Mihriye Mete, Mihriye Van Nostrand, Douglas Wu, Di Year: 20172016 Citation: Unpublished 2017/04/01 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Gomes Lima CJ Hall JP Khorjekar G McIver B Mete M Van Nostrand D Wu D Local accession number: A2017_313 Add to cart (remove)
	20.	How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit MedStar authors: Bethancourt, E Burman, Kenneth D Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2015_189 Add to cart (remove)
	21.	I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors: Atkins, Frank Brown, Taneshea A Moreau, Shari Van Nostrand, Douglas Wu, Di Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Atkins FB Brown TA Frey EC Lodge MA Moreau SL Plyku D Van Nostrand D Wu D Local accession number: A2017_004 Add to cart (remove)
	22.	Xerophthalmia and epiphora secondary to 131I therapy in patients with differentiated thyroid cancer: a prospective study. MedStar authors: Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Orquiza M Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_569 Add to cart (remove)
	23.	The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: a systematic review and meta-analysis. MedStar authors: Burman, Kenneth D Heimlich, Layla Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Library Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Heimlich SL Burman K Van Nostrand D. Wartofsky L Wu D Local accession number: B201890 Add to cart (remove)
	24.	Does pretreatment with lithium prior to radioactive iodine (RAI) therapy improve outcome in patients with metastatic differentiated thyroid cancer (DTC)? MedStar authors: Burman, Kenneth D Gomes Lima, Christiane J Van Nostrand, Douglas Wartofsky, Leonard Year: 20172016 Citation: Unpublished 2017/04/01 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Auh S Breymaier M Burman KD Cochran C et al. Gomes-Lima CJ Klubo-Gwiezdzinska J Van Nostrand D Wartofsky L Local accession number: A2017_312 Add to cart (remove)
	25.	Nationwide survey on the release of I-131 therapy patients to locations other than private residences. MedStar authors: Bloom, Gary Burman, Kenneth D Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2019 Citation: 2019/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Wu D, Bloom G, Burman K, Wartofsky L, Van Nostrand D. Local accession number: C2019_107 Add to cart (remove)
	26.	Pretreatment with lithium may be associated with improved overall survival in patients undergoing dosimetry-based radioactive iodine treatment (RAI) for metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Van Nostrand, Douglas Wartofsky, Leonard Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Auh S Burman KD Cochran C et al. Gomes-Lima C Luo H Tobey A Van Nostrand D Wartofsky L Zemskova M Local accession number: A2017_572 Add to cart (remove)
	27.	Lacrimal gland and nasolacrimal duct uptake on I-124 PET/CT imaging. MedStar authors: Burman, Kenneth D Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2019 Citation: 2019/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Wu D, Kulkarni K, Burman K, Wartofsky L, Van Nostrand D. Local accession number: C2019_108 Add to cart (remove)
	28.	The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors: Bethancourt, E Burman, Kenneth D Garcia, Carlos Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l Local accession number: 2015_192 Add to cart (remove)
	29.	A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors: Brennan, Michael T Hall, Jordan Khorjekar, Gauri Van Nostrand, Douglas Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Hall J Khorjekar G McIver B Van Nostrand D Wu D Zeymo A Local accession number: A2017_050 Add to cart (remove)
	30.	Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors: Bikas, A Burman, Kenneth D Desale, Sameer Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Mar 5 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D Local accession number: 2015_207 Add to cart (remove)
	31.	Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors: Burman, Kenneth D Kulkarni, Kanchan P Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Kharazi P Khorjekar G Kulkarni K Moreau S Van Nostrand D. Wartofsky L Wu D Local accession number: B2018215 Add to cart (remove)
	32.	The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors: Bethancourt, E Bikas, A Burman, Kenneth D Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l Local accession number: 2015_191 Add to cart (remove)
	33.	The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors: Bethancourt, E Bikas, A Burman, Kenneth D Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l Local accession number: 2015_190 Add to cart (remove)
	34.	Radioiodine dosimetry practices in the united states for differentiated thyroid cancer: preliminary report. MedStar authors: Burman, Kenneth D Gomes Lima, Christiane J Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Ylli, Dorina Year: 2019 Citation: 2019/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Pathology Form of publication: Poster Presentation All authors: Wu D...[Ylli D, Gomes-Lima C, Burman K, Wartofsky L, Van Nostrand], et al. Local accession number: C2019_78 Add to cart (remove)
	35.	New use for an old isotope. MedStar authors: Burman, Kenneth D Gomes Lima, Christiane J Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Ylli, Dorina Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Gomes Lima C Van Nostrand D. Wartofsky L Wu D Ylli D Local accession number: B201874 Add to cart (remove)
	36.	Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Garcia, Carlos A Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Kulkarni K Burman K Garcia C Van Nostrand D. Wartofsky L Wu D Local accession number: B201889 Add to cart (remove)
	37.	Assessment of serial comprehensive metabolic Panel ats following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors: Bikas, Athanasios Boulougoura, Afroditi Burman, Kenneth D Mirza, Faryal Vachhani, Shivangi Van Nostrand, Douglas Wartofsky, Leonard Year: 2016 Citation: Unpublished 2016/03/14 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K Local accession number: 2016_51 Add to cart (remove)
	38.	Assessment of serial complete blood counts following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors: Bikas, A Boyle, Lisa M Burman, Kenneth D Desale, Sameer Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Mar 9 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bikas A, Burman K, Desale S, Mete M, Boyle L, Wartofsky L, Van Nostrand D Local accession number: 2015_75 Add to cart (remove)
	39.	A new method to help determine whether a +Tg/-Dx scan patient with differentiated thyroid cancer may benefit from a dosimetrically-guided I-131 therapy. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 20172016 Citation: Unpublished 2017/04/01 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Gomes Lima CJ Kulkarni K Van Nostrand D Wartofsky L Wu D Local accession number: A2017_315 Add to cart (remove)
	40.	Prognostic factors in the overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Kulkarni, Kanchan P Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman KD Gomes-Lima C Kulkarni K Moreau S Van Nostrand D Wartofsky L Wu D Zeymo A Local accession number: A2017_570 Add to cart (remove)
	41.	Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors: Atkins, Francis Burman, Kenneth D Khorjekar, Gauri R Kulkarni, Kanchan Moreau, Shari Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L Local accession number: 2014.1_132 Add to cart (remove)
	42.	Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2014.1_133 Add to cart (remove)
	43.	Overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Kulkarni, Kanchan P Moreau, Shari L Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman KD Gomes-Lima CJ Kulkarni K Moreau SL Van Nostrand D Wartofsky L Wu D Zeymo A Local accession number: A2017_074 Add to cart (remove)
	44.	Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D Local accession number: 2014.1_134 Add to cart (remove)
	45.	Brain metastases from differentiated thyroid carcinoma: current therapies and outcomes. MedStar authors: Burman, Kenneth D Deeb, Hala Gomes-Lima, Christiane J Hritani, Rama Mete, Mihriye Punukollu, Sree Rao, Sarika Van Nostrand, Douglas Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Deeb H Gomes-Lima C Hritani R Jonklaas J Mete M Punukollu S Rao S Van Nostrand D Wu D Zeymo A Local accession number: A2017_568 Add to cart (remove)
	46.	Prevalence and survival analysis of patients with brain metastases from differentiated thyroid carcinoma in MedStar institutions. MedStar authors: Aulisi, Edward Burman, Kenneth D Deeb, Hala Gomes Lima, Christiane J Hritani, Rama Mete, Mihriye Punukollu, Sree Rao, Sarika Van Nostrand, Douglas Wu, Di Zeymo, Alexander Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Surgery/Neurosurgery Form of publication: Poster Presentation All authors: Aulisi E Burman K. Deeb H Gomes-Lima C Hritani R Jonklaas J Mete M Punukollu S Rao S Van Nostrand D Wu D Zeymo A Local accession number: B201879 Add to cart (remove)

Refine your search

Authors

Item types

Collections

Languages

Your search returned 46 results.